搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
Opinion
11 分钟
Opinion
Why People Itch and How to Stop It
Cruelest of all are the people who tell you not to scratch. They have a point, I admit. Scratching spurs cells in your immune ...
腾讯网
30 分钟
【探索重症哮喘诊治新纪元】10.20 广州—重度哮喘前沿临床研究与 ...
陈如冲教授 围绕生物制剂在哮喘治疗中的应用展开了讨论。从 20 世纪以来,哮喘治疗的目标已经从单纯的症状控制转变为实现临床缓解,即至少 12 个月无急性发作、缓解期间无需维持口服糖皮质激素(OCS)使用、肺功能稳定以及持续无明显哮喘症状 [8-9] ...
FiercePharma
1 小时
FDA approves Pfizer's RSV shot Abrysvo for all at-risk adults
While it’s a win for Pfizer over GSK and its RSV vaccine Arexvy, which is approved for those 50 and older, it’s difficult to ...
Derry Journal on MSN
4 小时
Inspirational NWRC graduate Rosie who battled chronic health issues while studying urges ...
A North West Regional College student (NWRC) who passed her Access Adult Learning Diploma despite battling chronic health ...
19 小时
U.S. FDA Approves Pfizer’s RSV Vaccine ABRYSVO® for Adults Aged 18 to 59 at Increased ...
Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved ABRYSVO® (Respiratory ...
Armed robbery in Revesby
8 小时
FDA Clears Pfizer RSV Vaccine for At-Risk Adults 18-59
Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved ABRYSVO ® (Respiratory Syncytial Virus Vaccine ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈